Close

Spectrum Pharma (SPPI) Says FDA Advisory Committee Votes that Qapzola Has Not Shown Substantial Evidence of Treatment Effect Over Placebo

September 14, 2016 1:07 PM EDT Send to a Friend
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login